Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale Director sold 10,000 shares at $42.19 ($421,900)
  2. 4 Open-market sale EVP and CCO sold 105,479 shares at an average $44.46 ($4,689,263)
  3. 4 Open-market sale EVP & General Counsel sold 17,500 shares at $45.06 ($788,576)
  4. 4 Open-market sale EVP and CCO sold 14,521 shares at an average $50.46 ($732,792)
  5. 4 Open-market sale EVP and CFO sold 36,000 shares at an average $49.66 ($1,787,853)
  6. 4 Open-market sale CEO sold 150,000 shares at an average $52.34 ($7,851,300)
  7. 4 Open-market sale President sold 2,160 shares at $46.41 ($100,246)
  8. CT ORDER Other Confidential Order
  9. 8-K Event Executive or director change
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. 4 Open-market sale Controller & PAO sold 147 shares at $39.65 ($5,829)
  13. 4 Open-market sale EVP and CCO sold 877 shares at $39.65 ($34,773)
  14. 4 Open-market sale President sold 1,031 shares at $39.65 ($40,879)
  15. 4 Open-market sale CEO sold 2,983 shares at $39.65 ($118,276)
  16. 4 Open-market sale CEO sold 150,000 shares at an average $40.15 ($6,022,749)
  17. SC 13D/A Stake Beneficial Ownership Report
  18. 4 Open-market buy Director bought 1,562,500 shares at $40.00 ($62,500,000)
  19. 8-K Event Other events
  20. 424B5 Offering Prospectus

Page 23 of 70 · 1,382 filings